Cargando…

Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India

BACKGROUND: Healthcare exposure may increase drug-resistant Enterobacteriaceae colonization risk. Nascent antimicrobial stewardship efforts in low- and middle-income countries require setting-specific data. We aimed to evaluate risk factors for inpatient drug resistant Enterobacteriaceae colonizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bharadwaj, Renu, Robinson, Matthew L, Balasubramanian, Usha, Kulkarni, Vandana, Kagal, Anju, Raichur, Priyanka, Khadse, Sandhya, Kadam, Dileep, Valvi, Chhaya, Kinikar, Aarti, Kanade, Savita, Suryavanshi, Nishi, Marbaniang, Ivan, Nelson, George, Johnson, Julia, Zenilman, Jonathan, Sachs, Jonathan, Gupta, Amita, Mave, Vidya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172743/
https://www.ncbi.nlm.nih.gov/pubmed/30286741
http://dx.doi.org/10.1186/s12879-018-3390-4
_version_ 1783361000155643904
author Bharadwaj, Renu
Robinson, Matthew L
Balasubramanian, Usha
Kulkarni, Vandana
Kagal, Anju
Raichur, Priyanka
Khadse, Sandhya
Kadam, Dileep
Valvi, Chhaya
Kinikar, Aarti
Kanade, Savita
Suryavanshi, Nishi
Marbaniang, Ivan
Nelson, George
Johnson, Julia
Zenilman, Jonathan
Sachs, Jonathan
Gupta, Amita
Mave, Vidya
author_facet Bharadwaj, Renu
Robinson, Matthew L
Balasubramanian, Usha
Kulkarni, Vandana
Kagal, Anju
Raichur, Priyanka
Khadse, Sandhya
Kadam, Dileep
Valvi, Chhaya
Kinikar, Aarti
Kanade, Savita
Suryavanshi, Nishi
Marbaniang, Ivan
Nelson, George
Johnson, Julia
Zenilman, Jonathan
Sachs, Jonathan
Gupta, Amita
Mave, Vidya
author_sort Bharadwaj, Renu
collection PubMed
description BACKGROUND: Healthcare exposure may increase drug-resistant Enterobacteriaceae colonization risk. Nascent antimicrobial stewardship efforts in low- and middle-income countries require setting-specific data. We aimed to evaluate risk factors for inpatient drug resistant Enterobacteriaceae colonization in a resource-limited setting in India. METHODS: Patients age ≥ 6 months admitted with ≥24 h of fever to a tertiary hospital in Pune, India were enrolled in a prospective cohort. Perirectal swabs, collected on admission and hospitalization day 3 or 4, were cultured in vancomycin- and ceftriaxone-impregnated media to assess for ceftriaxone-resistant Enterobacteriaceae (CTRE) and carbapenem-resistant Enterobacteriaceae (CPRE). Multivariable analyses assessed risk factors for drug-resistant Enterobacteriaceae colonization among participants without admission colonization. RESULTS: Admission perirectal swabs were collected on 897 participants; 87 (10%) had CTRE and 14 (1.6%) had CPRE colonization. Admission CTRE colonization was associated with recent healthcare contact (p < 0.01). Follow-up samples were collected from 620 participants, 67 (11%) had CTRE and 21 (3.4%) had CPRE colonization. Among 561 participants without enrollment CTRE colonization, 49 (9%) participants were colonized with CTRE at follow-up. Detection of CTRE colonization among participants not colonized with CTRE at admission was independently associated with empiric third generation cephalosporin treatment (adjusted odds ratio [OR] 2.9, 95% CI 1.5–5.8). Follow-up transition to CPRE colonization detection was associated with ICU admission (OR 3.0, 95% CI 1.0–8.5). CONCLUSIONS: Patients who receive empiric third generation cephalosporins and are admitted to the ICU rapidly develop detectable CTRE and CPRE colonization. Improved antimicrobial stewardship and infection control measures are urgently needed upon hospital admission. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3390-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6172743
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61727432018-10-15 Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India Bharadwaj, Renu Robinson, Matthew L Balasubramanian, Usha Kulkarni, Vandana Kagal, Anju Raichur, Priyanka Khadse, Sandhya Kadam, Dileep Valvi, Chhaya Kinikar, Aarti Kanade, Savita Suryavanshi, Nishi Marbaniang, Ivan Nelson, George Johnson, Julia Zenilman, Jonathan Sachs, Jonathan Gupta, Amita Mave, Vidya BMC Infect Dis Research Article BACKGROUND: Healthcare exposure may increase drug-resistant Enterobacteriaceae colonization risk. Nascent antimicrobial stewardship efforts in low- and middle-income countries require setting-specific data. We aimed to evaluate risk factors for inpatient drug resistant Enterobacteriaceae colonization in a resource-limited setting in India. METHODS: Patients age ≥ 6 months admitted with ≥24 h of fever to a tertiary hospital in Pune, India were enrolled in a prospective cohort. Perirectal swabs, collected on admission and hospitalization day 3 or 4, were cultured in vancomycin- and ceftriaxone-impregnated media to assess for ceftriaxone-resistant Enterobacteriaceae (CTRE) and carbapenem-resistant Enterobacteriaceae (CPRE). Multivariable analyses assessed risk factors for drug-resistant Enterobacteriaceae colonization among participants without admission colonization. RESULTS: Admission perirectal swabs were collected on 897 participants; 87 (10%) had CTRE and 14 (1.6%) had CPRE colonization. Admission CTRE colonization was associated with recent healthcare contact (p < 0.01). Follow-up samples were collected from 620 participants, 67 (11%) had CTRE and 21 (3.4%) had CPRE colonization. Among 561 participants without enrollment CTRE colonization, 49 (9%) participants were colonized with CTRE at follow-up. Detection of CTRE colonization among participants not colonized with CTRE at admission was independently associated with empiric third generation cephalosporin treatment (adjusted odds ratio [OR] 2.9, 95% CI 1.5–5.8). Follow-up transition to CPRE colonization detection was associated with ICU admission (OR 3.0, 95% CI 1.0–8.5). CONCLUSIONS: Patients who receive empiric third generation cephalosporins and are admitted to the ICU rapidly develop detectable CTRE and CPRE colonization. Improved antimicrobial stewardship and infection control measures are urgently needed upon hospital admission. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3390-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-04 /pmc/articles/PMC6172743/ /pubmed/30286741 http://dx.doi.org/10.1186/s12879-018-3390-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bharadwaj, Renu
Robinson, Matthew L
Balasubramanian, Usha
Kulkarni, Vandana
Kagal, Anju
Raichur, Priyanka
Khadse, Sandhya
Kadam, Dileep
Valvi, Chhaya
Kinikar, Aarti
Kanade, Savita
Suryavanshi, Nishi
Marbaniang, Ivan
Nelson, George
Johnson, Julia
Zenilman, Jonathan
Sachs, Jonathan
Gupta, Amita
Mave, Vidya
Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India
title Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India
title_full Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India
title_fullStr Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India
title_full_unstemmed Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India
title_short Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India
title_sort drug-resistant enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in pune, india
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172743/
https://www.ncbi.nlm.nih.gov/pubmed/30286741
http://dx.doi.org/10.1186/s12879-018-3390-4
work_keys_str_mv AT bharadwajrenu drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT robinsonmatthewl drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT balasubramanianusha drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT kulkarnivandana drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT kagalanju drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT raichurpriyanka drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT khadsesandhya drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT kadamdileep drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT valvichhaya drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT kinikaraarti drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT kanadesavita drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT suryavanshinishi drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT marbaniangivan drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT nelsongeorge drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT johnsonjulia drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT zenilmanjonathan drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT sachsjonathan drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT guptaamita drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia
AT mavevidya drugresistantenterobacteriaceaecolonizationisassociatedwithhealthcareutilizationandantimicrobialuseamonginpatientsinpuneindia